Abstract-Adenosine is known to play an important role in the regulation of coronary blood flow during metabolic stress.
T he nucleoside adenosine is a potent vasodilator that has been suggested to play a major role in the control of coronary blood flow during metabolic stress, such as hypoxia, 1 ischemia, 2 and increase in myocardial oxygen consumption. 3 Recently, adenosine receptors have been characterized in coronary vascular smooth muscle 4 and endothelial cells 5 ; however, the cellular signal pathway responsible for the vasodilation has not been systematically examined. The mechanisms implicated in adenosine-induced dilation of coronary arteries are controversial. For example, evidence suggests that endothelial production of nitric oxide (NO), 6 -8 stimulation of receptor-coupled G proteins, 9 and elevation of intracellular cAMP levels 10 -12 are involved in the dilation of isolated coronary arteries to adenosine. In an intact heart preparation, the increased coronary flow by adenosine was partly inhibited by the ATP-sensitive potassium (K ATP ) channel blocker glibenclamide 1 and by inhibition of adenylyl cyclase activity, 13 suggesting the putative role of K ATP channels and cAMP in this process. Conversely, evidence against the involvement of endothelium, 14, 15 NO, 16, 17 K ATP channels, 18 and cAMP 19, 20 in vasodilation to adenosine was also reported. Despite these discrepancies, it is important to note that the findings derived from both isolated conduit vessel and intact heart studies are generally confounded by various undefined factors. For example, because of the lack of vascular tone in vitro, the study of vasodilation in conduit vessels is performed with various pharmacological constrictors that potentially influence the adenosine response by activating and superimposing different contractile mechanisms. Most importantly, large-vessel studies are not representative of the resistance microvessels, where the blood flow is actually controlled, 21 and thus it is difficult to extrapolate the results from conduit vessel to microvessel because of the functional differences. In addition, the limitation of in vivo studies is also apparently caused by the inevitable influences from neurohumoral and local control mechanisms. Therefore, the cellular mechanism and signal transduction pathway for the vasomotor response to adenosine in coronary resistance vessels are still unclear.
Recently, Kuo and Chancellor 22 reported that dilation of isolated coronary arterioles to adenosine is attenuated by endothelial removal, NO synthase inhibitor, and glibenclamide, suggesting the involvement of endothelial NO release and K ATP channel activation. However, the release of NO from these microvessels has not been directly assessed, and the cellular pathways for NO and K ATP channel activation leading to vasodilation have not been elucidated. Whether cyclic nucleotides (cAMP/cGMP) are involved in this signal transduction process is also unclear. It has been shown that inhibition of G protein signal transduction by pertussis toxin (PTX) prevents the opening of K ATP channels in pancreatic cells 23 and cardiac myocytes, 24 suggesting the involvement of PTX-sensitive G proteins in K ATP channel activation. However, it is not known whether this transduction process also occurs in the vascular tissue, especially in response to adenosine. Therefore, in the present study, we focused on the cellular mechanism for adenosine-induced dilation. The role of endothelial NO, G proteins, cyclic nucleotides, and potassium channels in vasodilation to adenosine was examined in the isolated and pressurized coronary resistance vessels.
Materials and Methods

General Preparation
Pigs (8 to 12 weeks old of either sex) were sedated with an intramuscular injection of tiletamine and zolazepam (1:1, 4.4 mg/kg) and xylazine (2.2 mg/kg) and then anesthetized and heparinized with an intravenous administration of pentobarbital sodium (20 mg/kg) and heparin (1000 U/kg), respectively, via the marginal ear vein. Pigs were intubated and ventilated with room air. After a left thoracotomy was performed, the heart was electrically fibrillated, excised, and immediately placed in cold (5°C) saline solution. The procedures followed were in accordance with guidelines set by the Laboratory Animal Care Committee at Texas A&M University.
Isolation and Cannulation of Microvessels
The techniques for identification and isolation of porcine coronary microvessels were described previously. 25 In brief, a mixture of India ink and gelatin in physiological salt solution (PSS) containing (in mmol/L) NaCl 145.0, KCl 4.7, CaCl 2 2.0, MgSO 4 1.17, NaH 2 PO 4 1.2, glucose 5.0, pyruvate 2.0, EDTA 0.02, and MOPS 3.0 was perfused into the left anterior descending artery (0.3 mL) and the circumflex artery (0.4 mL) to enable visualization of coronary microvessels. Subepicardial arteriolar branches (50 to 100 m in internal diameter and 0.6 to 1.0 mm in length without branches) from the left anterior descending or circumflex arteries were selected and carefully dissected from the surrounding cardiac tissue under cold (5°C) PSS containing BSA (1%; Amersham) at pH 7.4. Each isolated arteriole was then transferred for cannulation to a methacrylic acid (Lucite) vessel chamber containing PSS-albumin equilibrated with room air at ambient temperature. One end of the microvessel was cannulated with a glass micropipette (40 m in tip diameter) filled with filtered PSS-albumin, and the outside of the microvessel was securely tied to the pipette with 11-0 ophthalmic suture (Alcon). The ink-gelatin solution inside the vessel was flushed out at a low perfusion pressure (Ͻ20 cm H 2 O). Then, the other end of the vessel was cannulated with a second micropipette and tied with suture. We have previously shown that the ink-gelatin solution has no detectable detrimental effect on either endothelial or vascular smooth muscle function. 26 In our previous studies, 22, 25, 26 we found that the isolated arterioles tend to maintain viability for a longer period of time when a small amount of albumin (1%) is present. The albumin used in our studies has no detectable effect on common vasomotor function, eg, endothelium-dependent and -independent agonist-induced dilations as well as myogenic and flow-induced responsiveness.
Instrumentation
The cannulated vessel was transferred to the stage of an inverted microscope (model IM35, Zeiss) coupled to a charge-coupled device camera (KP-161, Hitachi) and video micrometer (Microcirculation Research Institute, Texas A&M University Health Science Center). Internal diameters of the vessel were measured throughout the experiment using video microscopic techniques incorporated into the MacLab (ADInstruments Inc) data acquisition system. 26 The micropipettes were connected to independent reservoir systems, and intraluminal pressures were measured through sidearms of the 2 reservoir lines. The isolated vessels were pressurized without flow by setting both reservoirs at the same hydrostatic level. Leaks were detected by differences between reservoir pressure and intraluminal pressure. Preparations with leaks were excluded from further study.
Experimental Protocols for Mechanistic Study of Adenosine-Induced Dilation
Cannulated arterioles were bathed in PSS-albumin at 36°C to 37°C to allow development of basal tone. After vessels developed a stable basal tone (Ϸ40 to 60 minutes), the dose-diameter relationship for adenosine (0.1 nmol/L to 10 mol/L) was established. The role of endothelium in the adenosine-induced coronary arteriolar dilation was evaluated by comparing the response before and after endothelial removal. A nonionic detergent, CHAPS (0.4%), was perfused into the vessel for 1 to 2 minutes to remove endothelial cells. 27 To ensure that the vascular smooth muscle function was not compromised by CHAPS treatment, dose-dependent dilation of the vessel in response to sodium nitroprusside (1 nmol/L to 10 mol/L) was examined before and after denudation. Only vessels that exhibited normal basal tone, showed no vasodilation to endotheliumdependent vasodilator bradykinin (1 nmol/L), 27 and showed unaltered vasodilation to sodium nitroprusside after endothelial removal were accepted for data analysis.
The following studies were performed to elucidate the possible mechanisms involved in the coronary arteriolar dilation to adenosine. First, the involvement of NO and prostaglandins in adenosineinduced dilation was examined by extraluminal incubation (30 minutes) of isolated arterioles with the specific inhibitors N G -nitro-L-arginine methyl ester (L-NAME; 10 mol/L) and indomethacin (10 mol/L), respectively. Second, the possible involvement of endothelial K ATP channels in adenosine-induced vasodilation was examined by intraluminal incubation of vessels with glibenclamide (5 mol/L) for 10 minutes. This technique has been shown to specifically inhibit endothelial K ATP channel function in our previous study. 22 The role of vascular smooth muscle potassium channels was evaluated in denuded vessels treated with a nonspecific potassium channel inhibitor, tetraethylammonium (TEA, 10 and 20 mmol/L, extraluminal). 28 The involvement of K ATP and calcium-activated potassium (K Ca ) channels in vasodilation to adenosine was examined by extraluminal incubation of intact or denuded vessels with the specific inhibitors glibenclamide (5 mol/L, 30 minutes) 29 and iberiotoxin (0.1 mol/L, 60 minutes), 28 respectively. Third, the role of G proteins in adenosine-induced dilation was examined by extraluminal incubation (60 minutes) of the vessels with PTX (100 ng/mL) 30, 31 or cholera toxin (CTX, 2 g/mL). 9 Fourth, the dilation of denuded vessel to adenosine was performed in the presence of a depolarizing PSS solution containing 40 mmol/L KCl. The isotonic depolarizing solution was prepared by substituting 35 mmol/L NaCl with an equimolar amount of KCl. Finally, to examine the contribution of cAMP and cGMP, the vessels were treated with the cAMP-competitive antagonist Rp-8-Br-cAMPS (Biolog) 32 33 respectively. The vasodilation to adenosine was examined before and after extraluminal exposure of the vessels to each inhibitor. The efficacy of cAMP and cGMP inhibition was verified by the absence of vasodilation to 8-Br-cAMP (Research Biochemicals International) and sodium nitroprusside, respectively. It should be noted that glibenclamide has been shown to bind strongly, Ͼ99%, to albumin 34, 35 ; we performed studies with this K ATP channel blocker in the PSS without albumin.
Measurement of Adenosine-Induced NO Release from Coronary Microvessels
The porcine coronary arterioles (10 segments, 1 to 2 mm in length, 70 to 100 m in situ diameter) were isolated and placed in a microcentrifuge tube containing 100 L PSS at 37°C. After a 30-minute initial incubation, adenosine (10 L, final concentration 1 mol/L) was added to the vessel bath. The bathing solution was then collected for NO measurement after a 25-minute incubation with adenosine. The production of NO was evaluated by measuring nitrite using a chemiluminescence NO analyzer (Siever Instruments). Basically, the collected sample was injected into a reflux chamber containing glacial acetic acid and 1% potassium iodide at room temperature. Under these conditions, nitrite is quantitatively converted to NO. The NO gas was then purged into the chemiluminescence NO analyzer and quantified by reference to NaNO 2 standards. Another series of experiments was performed in the presence of NO synthase inhibitor. The vessels were treated with L-NAME (10 mol/L) for 30 minutes during the initial incubation period. Then, adenosine (1 mol/L final concentration) was added to the vessel bath and NO production was assayed after 25 minutes of incubation. In addition, a separate experiment was run as a control by adding vehicle solution (PSS) instead of adenosine and L-NAME. The background level of nitrite in the solution was measured from the tube containing PSS only, and this value was subsequently subtracted from the sampled solution to obtain NO production. The protein levels in each vessel tube were quantified by bicinchoninic acid protein assay (Pierce) and were used as a basis to normalize the NO production. The above NO measurements were performed in 4 independent sets of experiments, and the values were averaged.
Chemicals
Drugs were obtained from Sigma, except as specifically stated. Adenosine, bradykinin, iberiotoxin, indomethacin, L-NAME, CTX, PTX, sodium nitroprusside, 8-Br-cAMP, Rp-8-Br-cAMPS, and TEA were dissolved in PSS. Pinacidil was dissolved in ethanol. ODQ and glibenclamide were dissolved in DMSO as stock solutions (10 mmol/L). Subsequent concentrations of pinacidil, ODQ, and glibenclamide were diluted in PSS. The final concentrations of ethanol and DMSO in the vessel bath were 0.1 and 0.03%, respectively. Vehicle control studies indicated that these final concentrations of ethanol and DMSO had no effect on the arteriolar function.
Data Analysis
At the end of each experiment, the vessel was relaxed with sodium nitroprusside 100 mol/L to obtain its maximal diameter at 60 cm H 2 O intraluminal pressure. We have previously shown that this concentration of sodium nitroprusside produced maximal relaxation of isolated vessels. 36 Therefore, all diameter changes in response to agonists were normalized to the vasodilation in response to 100 mol/L sodium nitroprusside and expressed as a percentage of maximal dilation. All data are presented as meanϮSEM. Statistical comparisons of vasomotor responses and NO production under various treatments were performed with 1-or 2-way ANOVA when appropriate and tested with the Fisher protected least significant difference multiple-range test. Differences in resting diameter before and after pharmacological interventions and vasodilations to bradykinin and 8-Br-cAMP before and after intervention were compared by paired Student t tests. Significance was accepted at PϽ0.05.
Results
Role of Endothelium-Derived Factors in Vasodilation to Adenosine
In this study, all vessels developed a similar level of basal tone (68Ϯ1% of maximal diameter) at 36°C to 37°C bath temperature with 60 cm H 2 O intraluminal pressure. The average resting and maximal diameters of the vessel were 84Ϯ3 and 125Ϯ3 m, respectively. Indomethacin (10 mol/L) did not alter vasodilation elicited by adenosine, but L-NAME (10 mol/L) significantly inhibited the vasodilatory response (Figure 1 ). The inhibitory effect produced by L-NAME was identical to that produced by soluble guanylyl cyclase blocker ODQ (0.1 mol/L, Figure 1 ). Incubation of these vessels with L-NAME or ODQ did not significantly affect resting diameter.
Measurement of Adenosine-Induced NO Release From Coronary Arterioles
In the absence of adenosine, the NO production from coronary arterioles was Ϸ1.4Ϯ0.7 nmol/g protein. Adding adenosine (1 mol/L) to the vessels produced an 8-fold increase in NO production ( Figure 2 ). The increased NO production by adenosine (1 mol/L) was not seen in the vessels treated with L-NAME (10 mol/L) (Figure 2 ). There was no statistical difference in the NO production between control and L-NAME-treated vessels.
Role of Endothelial K ATP Channels in Adenosine-Induced Vasodilation
Intraluminal incubation of vessels with glibenclamide (5 mol/L, 10 minutes) did not alter resting diameter, but attenuated arteriolar dilation to adenosine (Figure 3 ). It is Figure 1 . Effect of cyclooxygenase, NO synthase, or guanylyl cyclase blockade on coronary arteriolar dilation to adenosine. Adenosine produced vasodilation of isolated coronary arterioles in a dose-dependent manner (resting diameter, 89Ϯ5 m; maximal diameter, 129Ϯ7 m; nϭ15). The vasodilatory response was not altered by indomethacin (10 mol/L; resting diameter, 90Ϯ6 m; maximal diameter, 132Ϯ8 m; nϭ5) but was significantly attenuated by extraluminal administration of L-NAME (10 mol/L; resting diameter, 99Ϯ7 m; maximal diameter, 136Ϯ10 m; nϭ5) or of ODQ (0.1 mol/L; resting diameter, 96Ϯ11 m; maximal diameter, 139Ϯ13 m; nϭ5). *PϽ0.05 control vs L-NAME or ODQ.
worth noting that the extent of attenuation by intraluminal glibenclamide was similar to that by L-NAME or ODQ ( Figure 1) . Furthermore, the addition of ODQ (0.1 mol/L, 30 minutes) to these intraluminal glibenclamide-treated vessels did not further attenuate vasodilation to adenosine ( Figure 3 ). These results suggest that intraluminal glibenclamide and ODQ inhibit the same vasodilatory pathway.
Role of G Proteins in Adenosine-Induced Vasodilation
Inhibition of arteriolar G i and G o proteins by extraluminal PTX (100 ng/mL, 60 minutes) did not alter resting vascular diameter or vasodilation to nitroprusside (Table) but significantly attenuated adenosine-induced vasodilation ( Figure  4A ). Removal of endothelium attenuated vasodilation to adenosine, and this attenuation was identical to that produced by PTX ( Figure 4A ). In these denuded vessels, PTX did not have an additional inhibitory effect on adenosine-induced vasodilation ( Figure 4A ). To evaluate the role of G s proteins in vasodilation, the intact vessels were treated with extraluminal CTX (2 g/mL) for 60 minutes, and its effect on adenosine-induced dilation was reexamined. Initially, CTX produced a slight vasodilation (17Ϯ5%) of coronary arterioles, but the vessels regained tone after a 15-minute exposure to CTX. In contrast to PTX, coronary arteriolar dilation to adenosine was not affected by CTX ( Figure 4B ).
Role of Vascular Smooth Muscle K ؉ Channels and Membrane Hyperpolarization in Arteriolar Dilation to Adenosine
The role of smooth muscle potassium channels and membrane hyperpolarization in vasodilation to adenosine is elucidated in Figures 5 and 6 . In this series of studies, the endothelium was initially removed to eliminate its contribution to vasodilation. Disruption of endothelium attenuated adenosine-induced vasodilation, which is consistent with the data shown in Figure 4A . Extraluminal incubation of denuded vessels with a nonspecific potassium channel blocker TEA (10 mmol/L) 28 attenuated vasodilation to adenosine ( Figure   5 ). A higher concentration of TEA (20 mmol/L) almost completely blocked the vasodilation (10% of maximal dilation, Figure 5 ). It is noted that 10 mmol/L TEA did not alter resting vessel tone, whereas 20 mmol/L TEA increased vessel tone from 68% to 61% of its maximal diameter without affecting dilation to sodium nitroprusside (Table) . To probe the role of K ATP channels in adenosine-induced dilation, the denuded vessels were treated with extraluminal glibenclamide for 30 minutes. Glibenclamide (5 mol/L) did not affect the resting diameter but completely blocked dilation of denuded vessels to adenosine ( Figure 6 ). It should be noted that the dilation of these glibenclamide-treated vessels to sodium nitroprusside was not affected (data not shown). In the presence of a high concentration of extraluminal KCl (40 mmol/L), adenosine-induced dilation was significantly attenuated (Figure 6 ). This concentration of KCl had a
Effect of Pharmacological Treatments on Dilation of Coronary Arterioles to Sodium Nitroprusside
20 mM TEA (nϭ3) 7Ϯ3 2 7 Ϯ7 6 3 Ϯ4 9 1 Ϯ2
All values are meanϮSEM expressed as percentage of maximal dilation. Dose-dependent dilation of isolated coronary arterioles to sodium nitroprusside was studied before and after pharmacological treatments. nϭnumber of vessels.
*PϽ0.05 vs control. Figure 2 . Measurement of NO production from isolated coronary arterioles. Adenosine (1 mol/L, nϭ4) caused a significant increase in NO production, in comparison with control (nϭ4), from coronary microvessels; this increased production was inhibited in the presence of NO synthase inhibitor L-NAME (10 mol/L, nϭ4). *PϽ0.05 vs control. 
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tendency to increase vascular tone but not in a significant manner and did not alter sodium nitroprusside-induced dilation (Table) . In contrast to TEA and glibenclamide, inhibition of K Ca channels by extraluminal iberiotoxin (0.1 mol/L) did not alter the vasodilatory response to adenosine (nϭ4, data not shown).
Role of cGMP in K ATP Channel-Mediated Vasodilation
Because the cGMP pathway is involved in the adenosineinduced dilation (Figure 1) , it is likely that the opening of smooth muscle K ATP channels is mediated by the activation of this pathway as shown in porcine pial arteries. 37 To examine this possibility, the NO donor sodium nitroprusside (10 nmol/L to 10 mol/L) was used to activate guanylyl cyclase for cGMP production, and the vasodilation produced by nitroprusside was examined after extraluminal administration of the K ATP channel antagonist glibenclamide. Coronary arteriolar dilation to sodium nitroprusside was not altered by glibenclamide (5 mol/L, Table) , but it was inhibited by the soluble guanylyl cyclase inhibitor ODQ (0.1 mol/L, Table) . These results indicate that activation of guanylyl cyclase does not lead to K ATP channel-mediated coronary arteriolar dilation.
Role of cAMP in Adenosine-Induced Vasodilation
The contribution of cAMP in coronary arteriolar dilation to adenosine was examined before and after extraluminal incubation of vessels with cAMP antagonist Rp-8-Br-cAMPS (10 mol/L, 40 minutes). As shown in Figure 7A , Rp-8-BrcAMPS abolished coronary arteriolar dilation in response to the direct increase in cAMP by a cell-permeable cAMP analog, 8-Br-cAMP (2 mmol/L); however, this cAMP antagonist failed to block adenosine-induced vasodilation ( Figure  7B) . To eliminate the possible confounding effects from endothelium, another series of experiments was performed in denuded vessels. Similarly, Rp-8-Br-cAMPS abolished dilation of denuded vessels to 8-Br-cAMP but failed to inhibit vasodilation to adenosine (nϭ3, data not shown). It is worth noting that resting diameter and sodium nitroprussideinduced dilation (Table) in these vessels were not altered by Rp-8-Br-cAMPS.
Role of cAMP in K ATP Channel-Mediated Vasodilation
To examine whether K ATP channels were involved in the cAMP-mediated dilation of coronary arterioles, the effect of glibenclamide (5 mol/L) on vasodilation to 8-Br-cAMP was investigated. 8-Br-cAMP (2 mmol/L) produced a significant vasodilation by increasing diameter from a control level of 89Ϯ3 m to 105Ϯ2 m, corresponding to 48% of maximal dilation. However, this dilation was not affected by glibenclamide (nϭ4, data not shown), indicating that cAMPinduced coronary arteriolar dilation is not mediated by the opening of K ATP channels.
Discussion
The role of the endothelium in dilation of coronary arteries to adenosine is controversial. For example, previous studies have shown that adenosine-induced dilation is independent, 14, 15 partially dependent, 7, 22, 38 or exclusively dependent 39 on the presence of an intact endothelium. Our previous 22 and the present studies using isolated and pressurized coronary arterioles demonstrated that the vasodilation to adenosine is partially dependent on the endothelium, given that the vasodilatory response was not abolished by endothelial removal (Figures 4A, 5, and 6 ). However, in some in vitro studies, the investigators did not observe the endothelial component of adenosine-induced dilation in large coronary arteries. 14, 15 This discrepancy may be derived from the difference in vascular preparations, ie, pressurized microvessel segment versus stretched vascular ring. In addition, the use of preconstrictors for large vessel preparations may have masked or interfered with the endothelial function. It is important to note that the development of basal tone in our coronary arterioles precluded the use of preconstrictors and thus eliminated these potential confounding effects. The activation of endothelial adenosine receptors may stimulate the production and release of endothelium-derived vasodilators. Administration of indomethacin to the coronary arterioles, with a concentration (10 mol/L) sufficient to block prostaglandin synthesis in our previous study, 26 did not alter adenosine responsiveness (Figure 1 ). This result indicates that adenosine-induced vasodilation is not mediated by the release of prostaglandins. Because adenosine-induced coronary arteriolar dilation was attenuated by the NO synthase inhibitor N G -monomethyl-L-arginine (L-NMMA) in our previous study 22 and by L-NAME in the present study ( Figure  1 ) and was inhibited to the same extent by endothelial removal ( Figures 4A, 5 , and 6), it is believed that endothelial production/release of NO is partially responsible for the observed adenosine response. This contention is directly supported by the result of NO measurement, which shows that NO production was increased after incubation of the coronary arterioles with adenosine ( Figure 2) . However, another possible explanation for the inhibitory effect by L-NAME and denudation is that basal production of NO plays a permissive or amplifying role in the adenosineinduced response. If NO indeed plays a permissive/amplifying role, we should see a restoration or enhancement of vasodilation in the denuded vessels in response to adenosine in the presence of a threshold concentration of NO donor sodium nitroprusside. In fact, we found that sodium nitroprusside (10 nmol/L) produced a slight dilation (5%; Table) of the denuded vessels but did not restore or enhance the adenosine response (data not shown). Collectively, our data indicate that NO is actively participating in the vasodilation rather than acting as a permissive or amplifying agent for the relaxing effect of adenosine.
Interestingly, our data showed that the endothelium was more sensitive than the vascular smooth muscle to adenosine for vasodilation, ie, dilation threshold 1 nmol/L and 0.1 mol/L for endothelium and smooth muscle, respectively ( Figures 4A, 5, and 6 ). This may suggest a dose-dependent activation of the NO-dependent versus NO-independent pathways for adenosine-induced vasodilation. For instance, the vasodilation at lower doses (Յ10 -8 mol/L) of adenosine is exclusively mediated by the NO (eg, abolished by L-NAME and denudation). In contrast, the higher doses (Ն10 -7 mol/L) of adenosine activate both NO-dependent and NOindependent pathways (Figures 1 and 3 ), but the latter pathway becomes more obvious and masks the NOdependent component. Therefore, the contribution of NO/endothelium to the observed vasodilation is diminished with increasing adenosine concentration. At the highest dose of 
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Coronary Arteriolar Dilation to Adenosineadenosine (10 -5 mol/L), the dilation occurs independently of NO or endothelium (Figures 1 and 4) . This might explain the seemingly conflicting results on NO dependency reported in vivo. For instance, flow responses to an intracoronary infusion (10 g/min) 40 or a bolus injection (3 g total) 6 of low doses of adenosine were attenuated by NO inhibitors. On the other hand, higher doses of adenosine (0.5 mg/min 41 or 8 mg/min 42 ) that produced maximal coronary dilation were not affected by NO inhibition. Therefore, these in vivo and our in vitro data support the notion that the contribution of NO/endothelium to adenosine-induced dilation is inversely related to the adenosine concentration. The dose-dependent activation of adenosine vasodilatory pathways in endothelial and smooth muscle cells is schematically illustrated in Figure 8 and discussed below.
As discussed above, the released NO is an important mediator for vasodilation in response to the lower concentrations of adenosine (Յ10 -7 mol/L). In general, NO released from the endothelium subsequently activates soluble guanylyl cyclase in underlying vascular smooth muscle cells and thus produces vasodilation. 43 However, a direct activation of vascular smooth muscle K ATP and K Ca channels by NO was also reported. 44, 45 Therefore, signal transduction mediating dilation of coronary arteries to adenosine downstream from NO remains unclear. In the present study, inhibition of soluble guanylyl cyclase by ODQ attenuated the vasomotor response to adenosine. In addition, ODQ attenuated adenosine-induced dilation similarly to that by L-NAME (Figure 1 ) and by denudation ( Figures 4A, 5, and 6) , and combined administration of these 2 inhibitors did not further enhance the inhibition (data not shown), suggesting the involvement of the guanylyl cyclase/cGMP pathway in this vasodilatory process. On the other hand, glibenclamide and iberiotoxin did not affect vasodilation to NO donor sodium nitroprusside (Table) , indicating that adenosine-induced dilation associated with NO is not mediated by the opening of K ATP and K Ca channels in our preparation. In addition, ODQ attenuated adenosine-induced dilation in a manner identical to that by L-NAME (Figure 1) and denudation (Figures 4A, 5, and 6) , and combined administration of these 2 inhibitors did not further enhance the inhibition (data not shown). It appears that activation of the NO/guanylyl cyclase pathway is responsible for the endothelium-dependent component of vasodilation to adenosine (Figure 8) .
It has been shown that the membrane hyperpolarization leading to the influx of calcium into endothelial cells is necessary for the NO production from constitutive NO synthase during agonist stimulation. 46 Interestingly, adenosine has been shown to produce a sustained hyperpolarization of cultured coronary endothelial cells. 47 Recently, Kuo and Chancellor 22 demonstrated that prevention of endothelial hyperpolarization by a high luminal KCl solution attenuated dilation of isolated porcine coronary arterioles to adenosine. This inhibitory effect is consistent with that elicited by L-NMMA, indicating that hyperpolarization of the endothelium by adenosine might be responsible for the release of NO (Figure 8 ). In our previous study, we speculated that the membrane hyperpolarization might be a result of opening of endothelial K ATP channels, given that specific inhibition of endothelial K ATP channel and prevention of endothelial hyperpolarization by intraluminal administration of glibenclamide and KCl, respectively, produce identical inhibition of coronary arteriolar dilation to adenosine. 22 In the present study, inhibition of endothelial K ATP channels by luminal glibenclamide attenuated adenosine-induced vasodilation in a manner identical to that produced by L-NAME (Figure 1 ), ODQ (Figure 1) , and endothelial removal ( Figures 4A, 5 , and 6). Furthermore, subsequent administration of ODQ to vessels pretreated with luminal glibenclamide did not further enhance the inhibitory effect (Figure 3 ), suggesting that these inhibitors act on the same pathway for vasodilation. Because luminal glibenclamide did not affect vasodilation to NO donor nitroprusside, 22 the inhibition of adenosine-induced dilation by luminal glibenclamide is believed to be upstream of the NO-cGMP pathway. Altogether, these results suggest that the opening of endothelial K ATP channels leads to membrane hyperpolarization for calcium influx and thus produces vasodilation through subsequent activation of NO synthase for NO production (Figure 8 ).
The opening of endothelial K ATP channels by adenosine may involve activation of G proteins as suggested by patchclamp studies in cardiac myocytes. 24 It has been shown that adenosine receptors can be coupled to both G s and G i proteins in various types of tissues. 48, 49 In the present study, we found that G s proteins do not play a role in coronary arteriolar dilation to adenosine, because CTX did not alter the vasodilatory response. In contrast, PTX attenuated adenosineinduced dilation to the same extent as L-NAME, ODQ, intraluminal glibenclamide, or denudation. It appears that the component of PTX-sensitive dilation resides in the endothe- Opening of these channels elicits a change in membrane potential (⌬Em; ie, hyperpolarization), leading to an influx of calcium for NO production by NO synthase (NOS). The endotheliumreleased NO diffuses to the underlying smooth muscle and stimulates guanylyl cyclase to produce cGMP for relaxation. At the higher concentrations of adenosine (Ն0.1 mol/L), the vasodilatory action is more dependent on the smooth muscle K ATP channels that take over the role of NO for vasodilation, even though the release of NO is still present under this condition. The opening of the smooth K ATP channels elicits membrane hyperpolarization and subsequent relaxation. Inhibition of these signaling pathways by their respective inhibitors is indicated by a minus sign.
lium, because the adenosine-induced response was not inhibited by PTX in denuded vessels ( Figure 4A ). Furthermore, PTX did not further enhance the inhibitory effect produced by L-NAME, ODQ, or luminal glibenclamide (nϭ3, data not shown). Collectively, our present results support the contention that the activation of endothelial PTX-sensitive G proteins is coupled to the opening of endothelial K ATP channels for membrane hyperpolarization and subsequently leads to vasodilation through the release of NO (Figure 8) .
At the higher concentrations of adenosine (Ͼ0.1 mol/L), the contribution of endothelium-released NO to vasodilation is diminished, and the direct action of adenosine on smooth muscle predominates. Because potassium channels have been shown to play an important role in smooth muscle relaxation, 28 in the present study we examined the possible involvement of these channels in adenosine-induced dilation of denuded coronary arterioles. The role of potassium channels in the vasodilation to adenosine was evident because the adenosine response was inhibited by a nonspecific potassium channel blocker, TEA. Although the concentrations of TEA (10 and 20 mmol/L) are likely to inhibit both K ATP and K Ca channels, 28 the role of K Ca channels is not supported, because the dilation was not altered by iberiotoxin. In contrast, inhibition of K ATP channels by glibenclamide abolished the adenosine response, suggesting that opening of K ATP channels in vascular smooth muscle is responsible for the endothelium-independent response to adenosine ( Figure 6 ). It is likely that vascular hyperpolarization after the opening of smooth muscle K ATP channels results in vasodilation, because administration of a depolarizing agent, KCl (40 mmol/L), significantly attenuated adenosine-induced dilation ( Figure 6 ). A higher concentration of KCl (60 mmol/L) nearly abolished the vasodilatory response (7% dilation, data not shown). However, the latter data are difficult to interpret, because the resting vessel diameter was significantly decreased, from 63% to 44% of its maximal diameter, by 60 mmol/L KCl. Nevertheless, these results suggest that the activation of smooth muscle K ATP channels leading to vascular hyperpolarization is an essential pathway for vasodilation to adenosine (Figure 8 ). It is important to note that adenosine-induced dilation of large porcine coronary arteries was unaffected by glibenclamide, 18 indicating that heterogeneous vasodilatory mechanisms might exist in the coronary circulation. On the other hand, it should be noted that this disparate result might be related to the vessel size, different vascular preparations, and the use of preconstrictors in these large vessels. 18 It is generally believed or assumed that stimulation of adenosine receptors activates adenylyl cyclase in vascular smooth muscle to produce cAMP, which may in turn relax coronary arteries by activating cAMP-dependent protein kinase A. 10 -12 However, there is no direct evidence to support this contention in the coronary microcirculation. In fact, there are some doubts as to the role of cAMP pathway in adenosine-induced dilation of coronary arteries, because adenosine and adenosine receptor agonists seem not to increase intracellular levels of cAMP in coronary arteries in vitro. 19, 20 In the present study, we found that the dilation elicited by adenosine was not affected by cAMP antagonist Rp-8-BrcAMPS, suggesting a minimal role of this pathway, if any, in vasodilation. The concentration of cAMP antagonist used in the present study was effective and selective, given that vasodilation to cAMP analog 8-Br-cAMP ( Figure 7A ) was abolished, and the cGMP-mediated dilation in response to sodium nitroprusside (Table) remained intact. The present study also ruled out the possibility of activation of K ATP channels by the cAMP-protein kinase A pathway, 50 because vasodilation to cAMP agonist was not altered by glibenclamide. Collectively, the ability of glibenclamide but not of Rp-8-Br-cAMPS to inhibit vasodilation indicates that the activation of K ATP channels by adenosine is not mediated by the cAMP pathway. Furthermore, our data do not support the idea that activation of K ATP channels by adenosine is through the cGMP pathway, because vasodilation in response to sodium nitroprusside was not affected by glibenclamide (Table) . Unlike the endothelium, the K ATP channel activation in smooth muscle appears to be independent of G i /G o proteins, because PTX (100 ng/mL, 60-minute incubation) had no effect on adenosine-induced dilation in the denuded vessels. In our previous study, we have shown that the same PTX treatment produced an effective inhibition of acidosisinduced dilation mediated by the opening of smooth muscle K ATP channels. 31 Therefore, the failure of inhibiting adenosine-induced dilation of denuded vessels by PTX in the present study is unlikely the result of the ineffectiveness of this drug. Nevertheless, these findings highlight the involvement of different signaling pathways in the activation of smooth muscle K ATP channel by adenosine (PTX insensitive) and by acidosis (PTX sensitive).
In conclusion, porcine coronary arteriolar dilation to adenosine could be explained by at least 2 mechanisms. First, adenosine, at lower concentrations (eg, nmol/L range), selectively opens endothelial K ATP channels through activation of PTX-sensitive G proteins. This signaling leads to the production and release of NO, which subsequently activates smooth muscle soluble guanylyl cyclase for vasodilation. Second, at higher concentrations of adenosine (eg, mol/L range), the opening of smooth muscle K ATP channels associated with membrane hyperpolarization takes over the role of NO for vasodilation. It appears that the latter vasodilatory pathway is independent of G proteins and of cAMP/cGMP pathways. Currently, the detailed mechanism for the inverse relationship between adenosine concentration and the involvement of endothelium in vasodilation is unclear. It is possible that the G proteins in endothelium might serve as an amplifier for the cellular signaling linked to K ATP channels and thus might contribute to the high sensitivity of endothelium to adenosine. Therefore, a low concentration of adenosine is sufficient to activate the endothelial K ATP channel pathway for vasodilation. In contrast, a higher concentration of adenosine is required to activate smooth muscle K ATP channels, because the PTX-sensitive G protein is not involved in this vasodilatory pathway. This might explain the differential sensitivity of the adenosine response, in terms of endothelium versus smooth muscle pathway for vasodilation.
